TrialCancer2026
A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma.
Yousef Zakharia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it
TrialCancer2026
Yousef Zakharia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.